πŸ‡ΊπŸ‡Έ FDA
Patent

US 6800619

Caspase inhibitors and uses thereof

expired A61PA61P1/00A61P1/04

Quick answer

US patent 6800619 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 05 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18